RELMADA THERAPEUTICS, INC. — Director's Dealing 2015

Jan 16, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-01-06

Reporting Person: BECK DOUGLAS (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options	$0.80	2023-12-02	Common Stock (334199)		Direct

Footnotes

F1: The options were granted on December 2, 2013 (the "Grant Date"). The stock options vest on the Grant Date based on the following vesting schedule: Twenty-five percent (25%) of the stock options of the Initial Grant shall vest on the first anniversary of the Grant Date and the remaining seventy-five percent (75%) shall vest in equal quarterly increments of 6.25% of the option grant over the following three (3) year period.